Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: szentecyclolabhu

June 2, 2025 Drug delivery / Pharma applications

Does a Gut-Joint Axis exist? (Potential Role of bile acids and microbiome in Osteroarthritis treatment)

The gut-joint axis is a bidirectional communication and interaction between the gastrointestinal tract (gut) and the joints. It involves the

Continue reading

May 6, 2025 CD derivatives / E-ducation

A comprehensive nomenclature system for cyclodextrins

Modified cyclodextrins (CDs) are cyclic oligosaccharides with many applications in drug delivery, catalysis, and as active pharmaceutical ingredients. In general,

Continue reading

April 1, 2025 Life sciences

Polyvinyl alcohol, N-acetylcysteine, and methyl-β-cyclodextrin exhibit albumin functions in natural killer cell culture

Albumin is a crucial component of serum-free media, playing a significant role in ex vivo cell culture as a lipid carrier

Continue reading

March 4, 2025 Analysis / CD derivatives

Mirror-Image Cyclodextrins: Actions and Interactions

A recent report of the Nobel laureate, Sir Fraser Stoddart’s team on the first synthesis of unnatural mirror-image l-cyclodextrins foreshadows a

Continue reading

February 25, 2025 Drug delivery / Pharma applications

Possible treatment of brain tuberculosis by methyl-β-cyclodextrin–assisted trans-nasal delivery of anti-tuberculosis drugs

Tuberculosis (TB) is prevalent worldwide. One of the most life-threatening manifestation of extrapulmonary tuberculosis is the involvement of central nervous

Continue reading

January 13, 2025 CD as API / Drug delivery / Pharma applications

Winners of 2024 Lasker-DeBakey Clinical Medical Research Award for their pioneering works on GLP-1-based therapy for obesity

This year Lasker-De Bakey Clinical Medical Research Award honoured three scientists for their discovery and development of glucagon-like peptide-1 (GLP-1)-

Continue reading

January 9, 2025 Events

Message from Prof. Takashi Hayashita (Sophia University)

The following message arrived from Prof. Takashi Hayashita: This is Takashi Hayashita (Sophia University) from the Society of Cyclodextrin, Japan

Continue reading

January 8, 2025 CD derivatives / Events / Other industrial use

Sir Fraser Stoddart (1942-2024)

It is with deep sadness that the Cyclodextrin News shares the passing of Sir Fraser Stoddart, a Giant in the

Continue reading

November 6, 2024 CD as API / Pharma applications

More and more manipulated results in Alzheimer and Parkinson’s research

 „Short road to discovery, winding road to use”                                                                                                 Josef Pitha I assume that many of you remember the “story”

Continue reading

September 11, 2024 Drug delivery / Pharma applications

A new therapeutic approach to neurodegeneration? An old, known drug restarts flow of brain-cleaning fluids

On 15 August, 2024 Douglas Kelley, professor of mechanical engineering at the University of Rochester and his co-workers published that

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 … 7 Next Posts»

Recent Posts

  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Special issue: Novel macrocycles: from synthesis to supramolecular function
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer’s disease

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (67)
  • CD as API (347)
  • CD derivatives (411)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (793)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (223)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (401)
  • Other industrial use (106)
  • Pharma applications (1,186)
  • Supramolecular systems (40)
  • Uncategorized (149)

Top Posts

  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease
  • How air fresheners work?
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...